SIMONINI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 16.834
EU - Europa 10.128
AS - Asia 7.484
SA - Sud America 1.242
Continente sconosciuto - Info sul continente non disponibili 355
AF - Africa 235
OC - Oceania 139
Totale 36.417
Nazione #
US - Stati Uniti d'America 16.477
RU - Federazione Russa 3.749
IT - Italia 2.625
SG - Singapore 2.191
CN - Cina 1.631
HK - Hong Kong 1.134
BR - Brasile 995
IE - Irlanda 944
VN - Vietnam 855
SE - Svezia 689
KR - Corea 666
PL - Polonia 462
FR - Francia 376
DE - Germania 318
IN - India 278
FI - Finlandia 275
GB - Regno Unito 221
CA - Canada 201
UA - Ucraina 148
AU - Australia 139
ES - Italia 117
TR - Turchia 114
BD - Bangladesh 108
JO - Giordania 104
AR - Argentina 98
JP - Giappone 88
ID - Indonesia 67
MX - Messico 65
CH - Svizzera 49
NL - Olanda 48
IQ - Iraq 45
ZA - Sudafrica 42
CI - Costa d'Avorio 37
EC - Ecuador 36
NG - Nigeria 31
AT - Austria 30
SC - Seychelles 28
SA - Arabia Saudita 24
PK - Pakistan 23
EG - Egitto 22
MA - Marocco 22
PY - Paraguay 22
CL - Cile 21
VE - Venezuela 20
CO - Colombia 19
IR - Iran 18
AZ - Azerbaigian 17
CR - Costa Rica 17
AE - Emirati Arabi Uniti 15
BE - Belgio 14
TH - Thailandia 14
KE - Kenya 13
PE - Perù 13
KZ - Kazakistan 12
UZ - Uzbekistan 12
HN - Honduras 11
PH - Filippine 11
JM - Giamaica 10
BO - Bolivia 9
DZ - Algeria 9
TT - Trinidad e Tobago 9
CZ - Repubblica Ceca 8
DO - Repubblica Dominicana 8
GT - Guatemala 8
LT - Lituania 8
OM - Oman 8
UY - Uruguay 8
LV - Lettonia 6
PS - Palestinian Territory 6
BG - Bulgaria 5
BH - Bahrain 5
IL - Israele 5
MU - Mauritius 5
NP - Nepal 5
PA - Panama 5
PR - Porto Rico 5
RO - Romania 5
SV - El Salvador 5
AL - Albania 4
BJ - Benin 4
ET - Etiopia 4
LB - Libano 4
MY - Malesia 4
TN - Tunisia 4
AO - Angola 3
BN - Brunei Darussalam 3
BS - Bahamas 3
CG - Congo 3
EE - Estonia 3
NI - Nicaragua 3
NO - Norvegia 3
RS - Serbia 3
TW - Taiwan 3
BB - Barbados 2
BW - Botswana 2
CY - Cipro 2
DK - Danimarca 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
Totale 36.028
Città #
Santa Clara 3.358
Ashburn 1.785
Singapore 1.587
Fairfield 1.250
Dublin 936
Hong Kong 912
Chandler 888
Seoul 665
Milan 571
Woodbridge 542
Seattle 508
Cambridge 499
Houston 468
Warsaw 448
Wilmington 447
Dallas 443
San Jose 438
Beijing 394
Lawrence 380
Altamura 373
The Dalles 315
Council Bluffs 302
Princeton 292
Ho Chi Minh City 278
Hefei 273
Los Angeles 263
Lauterbourg 235
Buffalo 231
Moscow 216
Boston 207
Rome 205
Hanoi 199
Ann Arbor 198
Jacksonville 198
Mumbai 154
New York 145
Florence 140
Melbourne 125
Medford 112
Munich 102
Boardman 100
San Diego 94
Clifton 89
Shanghai 83
Izmir 82
London 82
Tokyo 82
São Paulo 72
Kent 71
Barcelona 60
Naples 56
Helsinki 55
Bologna 54
Toronto 50
Turin 50
Paris 49
Da Nang 48
Falls Church 47
Turku 45
Redondo Beach 44
Figino 43
Bern 42
Palermo 42
Norwalk 39
Abidjan 37
Jakarta 37
Pune 36
Miano 35
Orem 32
Chicago 31
Bari 30
Chennai 30
Haiphong 30
Montreal 30
Rio de Janeiro 30
Guangzhou 29
Hillsboro 29
Abuja 28
Frankfurt am Main 28
Vienna 28
Genoa 26
Yubileyny 26
Johannesburg 25
Brooklyn 22
Verona 22
Curitiba 21
Denver 21
Lappeenranta 21
Phoenix 21
Atlanta 20
Belo Horizonte 20
Frankfurt Am Main 20
Salerno 19
Columbus 18
Porto Alegre 18
Brescia 17
Dong Ket 17
Tianjin 17
Venice 17
Andover 16
Totale 23.465
Nome #
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 306
The intestinal microbiota in enthesitis-related arthitis 277
Common symptoms for a rare disease in a girl with sarcoidosis: a case report 263
SAPHO syndrome in pediatric patients with inflammatory bowel disease treated with infliximab 250
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 244
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 244
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies 243
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 237
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports 235
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 231
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. 226
Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: The evidence from a systematic review and meta-analysis approach. 218
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 215
Anti-adalimumab antibodies purified from juvenile idiopathic arthritis patients: kinetic characterization among biosimilars 214
Kawasaki disease: an epidemiological study in central Italy 214
Anticorpi anti-istone: È sempre lupus indotto da farmaci? 214
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 207
Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system 203
Design, synthesis, and biological activity of tumor necrosis factor-alpha peptides for adalimumab recognition 201
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 199
Describing Kawasaki shock syndrome: results from a retrospective study and literature review 199
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. 195
Kawasaki disease in infants less than one year of age: An Italian cohort from a single center 194
Bone status over one-year etanercept treatment in juvenile idiopathic arthritis 193
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 190
Mycophenolate mofetil-induced hypogammaglobulinemia and infectious disease susceptibility in pediatric patients with chronic rheumatic disorders: a monocentric retrospective study 189
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients 188
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 187
Common variable immunodeficiency presenting as sarcoidosis in a 9-year-old child 187
Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report. 185
Oxidative stress in Systemic Sclerosis. 184
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach 183
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. 182
Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis. 181
Pediatric Osteoporosis: Diagnosis and Treatment Considerations 181
Joint pain management in children and adolescents 179
Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. 178
Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in italian children 177
Acute febrile cholestasis as inaugural manifestation of Kawasaki’s disease. 177
Changing evidence over time: Updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis 177
Anakinra treatment in drug-resistant Behcet's disease: a case series. 177
Childhood uveitis 174
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. 174
Amoxicillin Adverse Cutaneous Reaction Versus Post Streptococcal Vasculitis: Lymphocyte Transformation Test Solved the Question 173
Be Aware of the Risk of Phlebotominae 173
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment 170
The off-label use of anakinra in pediatric systemic autoinflammatory diseases 170
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 169
Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis 169
The decrease of Kawasaki syndrome during the second COVID-19 wave: a potential, unexpected effect of social distancing 168
Idiopathic calcinosis in a paediatric patient 168
Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. 168
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) 168
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 167
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity? 165
Splenomegaly in Kawasaki Disease: A Pitfall in Diagnosis 164
Clinical features and outcome of Cogan syndrome. 164
CD4+CD161+cells with Th1 or Th17/Th1 profile accumulate in the synovial fluid of patients with oligo- and polyarticular juvenile idiopathic arthritis 163
Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration 162
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 162
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. 161
Ocular involvement in monogenic autoinflammatory disease: A systematic literature review 161
Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review 160
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature. 160
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 160
Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study. 159
Anticoagulation and Thrombotic Events in the Multisystem Inflammatory Syndrome in Children: Experience of a Single-center Cohort and Review of the Literature 158
Coeliac disease in patients with Kawasaki disease. Is there a link? 158
Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey 158
Artrite idiopatica giovanile: valutazione ecografica delle articolazioni temporomandibolari 158
Long-term follow-up of coronary artery lesions in children in Kawasaki syndrome 157
Sarcoidosi pediatrica: Esiste davvero? 156
The conundrum of juvenile spondyloarthritis classification: Many names for a single disease? Lesson learned from an instructive clinical case 156
STAT3-confusion-of-function: Beyond the loss and gain dualism 155
Sequential MR angiography in childhood primary angiitis of the CNS. 155
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 155
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis 155
CD38high/HLA-DR+CD8+ T lymphocytes display pathogen-specific expansion regardless of hemophagocytic lymphohistiocytosis 154
Bilateral renal artery stenosis in Kawasaki disease: a report of two cases. 154
OBSIDIAn - real world evidence of Originator to BioSImilar Drug switch in juvenile idiopathic arthritis 154
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 154
Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis 154
Acute hemorrhagic edema of infancy: 20‐year experience from an Italian tertiary referral center 153
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis. 153
Craniofacial morphology in a cohort of juvenile idiopathic arthritis children. 153
CD38high/HLA-DR+ CD8+ T cells as potential biomarker of hemophagocytic lymphohistiocytosis secondary to visceral Leishmania infection 152
Acute febrile cholestasis as an inaugural manifestation of kawasaki’s disease 152
Severe A(H1N1)pdm09 influenza acute encephalopathy outbreak in children in Tuscany, Italy, December 2023 to January 2024 151
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 151
Successful treatment of adalimumab in a child with Vogt-Koyanagi-Harada: which is the best available systemic treatment? 151
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 151
 A Rare Case of Neonatal Antiphospholipid Syndrome 151
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 150
Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status? 150
Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: Do we need a consensus? 150
Etanercept inhibits the TNF-α driven shifting of Th17 towards non-classic Th1 phenotype in juvenile idiopathic arthritis. 150
Cervical arthritis as early manifestation of enthesitis-related arthritis complicated by uveitis 150
Moving from nature to nurture: a systematic review and meta-analysis of environmental factors associated with juvenile idiopathic arthritis 149
Too young to fail: a case report on the effectiveness of tocilizumab for paediatric systemic sclerosis-associated interstitial lung disease 149
Diagnosing Kawasaki syndrome: the need for a new clinical tool. 148
Totale 17.881
Categoria #
all - tutte 111.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.687


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.702 0 222 196 110 35 51 61 156 47 39 271 514
2022/20234.214 421 957 173 270 278 752 523 201 381 31 140 87
2023/20241.523 60 176 277 87 103 265 66 254 42 79 84 30
2024/202510.101 392 1.089 588 1.541 2.993 1.194 158 505 562 277 412 390
2025/202612.409 1.237 1.771 1.173 1.083 1.210 449 1.441 566 637 634 326 1.882
2026/2027815 439 376 0 0 0 0 0 0 0 0 0 0
Totale 36.417